Stereotaxis, Inc. STXS | $35.71M | 16.55 | 13.68M | 0% | +$0 | 8.3 | |
2seventy bio, Inc. TSVT | $6.44M | 2.34 | 1.2M | -16.82% | -$1.3M | 1.5 | |
AxoGen, Inc. AXGN | $7.55M | 2.14 | 935,894 | 0% | +$0 | 1.76 | |
KalVista Pharmaceuticals, Inc. KALV | $9.57M | 1.91 | 806,973 | +34.27% | +$2.44M | 2.23 | |
Regulus Therapeutics Inc. RGLS | $3.08M | 1.64 | 1.07M | -3.65% | -$116,642.87 | 0.72 | |
Century Therapeutics, Inc. IPSC | $5.46M | 1.57 | 1.31M | 0% | +$0 | 1.27 | |
Accuray Incorporated ARAY | $3.02M | 1.23 | 1.22M | 0% | +$0 | 0.7 | |
ProQR Therapeutics N.V. PRQR | $2.07M | 1.11 | 905,582 | -3.72% | -$80,146.49 | 0.48 | |
Larimar Therapeutics, Inc. LRMR | $4.98M | 1.03 | 656,373 | +102.66% | +$2.52M | 1.16 | |
Alector, Inc. ALEC | $5.5M | 0.95 | 912,928 | +49.68% | +$1.82M | 1.28 | |
Inogen, Inc. INGN | $1.68M | 0.89 | 208,790 | +1,291.93% | +$1.56M | 0.39 | |
Syndax Pharmaceuticals, Inc. SNDX | $15.7M | 0.78 | 659,574 | -11.18% | -$1.98M | 3.65 | |
Day One Biopharmaceuticals, Inc. DAWN | $11.01M | 0.76 | 666,463 | -2.91% | -$330,400.01 | 2.56 | |
Lineage Cell Therapeutics, Inc. LCTX | $2.02M | 0.72 | 1.37M | New | +$2.02M | 0.47 | |
Merus N.V. MRUS | $17.07M | 0.65 | 378,995 | -16.68% | -$3.42M | 3.97 | |
Gossamer Bio, Inc. GOSS | $1.66M | 0.62 | 1.41M | -4.53% | -$78,812.19 | 0.39 | |
IDEAYA Biosciences, Inc. IDYA | $19.59M | 0.59 | 446,341 | -13.56% | -$3.07M | 4.55 | |
AtriCure, Inc. ATRC | $8.24M | 0.56 | 271,029 | +115.91% | +$4.43M | 1.92 | |
Aquestive Therapeutics, Inc. AQST | $2.13M | 0.55 | 500,000 | New | +$2.13M | 0.5 | |
Kura Oncology, Inc. KURA | $8.8M | 0.54 | 412,663 | -16.24% | -$1.71M | 2.05 | |
Perspective Therapeutics, Inc. CATX | $3.69M | 0.49 | 3.1M | New | +$3.69M | 0.86 | |
Morphic Holding, Inc. MORF | $8.16M | 0.46 | 231,748 | 0% | +$0 | 1.9 | |
Sutro Biopharma, Inc. STRO | $1.89M | 0.41 | 334,079 | +18.02% | +$288,149.95 | 0.44 | |
Astria Therapeutics, Inc. ATXS | $3.14M | 0.41 | 223,265 | -50.28% | -$3.18M | 0.73 | |
Tandem Diabetes Care, Inc. TNDM | $9.14M | 0.4 | 258,208 | +16.99% | +$1.33M | 2.13 | |
Xenon Pharmaceuticals Inc. XENE | $11.78M | 0.36 | 273,739 | -1.08% | -$129,150.00 | 2.74 | |
COMPASS Pathways plc CMPS | $2.02M | 0.36 | 243,210 | +26.02% | +$417,747.16 | 0.47 | |
Cytokinetics, Incorporated CYTK | $27.91M | 0.35 | 398,100 | -0.47% | -$133,209.00 | 6.49 | |
BioCryst Pharmaceuticals, Inc. BCRX | $3.6M | 0.34 | 709,500 | 0% | +$0 | 0.84 | |
Edgewise Therapeutics, Inc. EWTX | $5.59M | 0.33 | 306,197 | -31.86% | -$2.61M | 1.3 | |
Revolution Medicines, Inc. RVMD | $16.5M | 0.31 | 511,894 | 0% | +$0 | 3.84 | |
Bicycle Therapeutics plc BCYC | $3.04M | 0.29 | 122,200 | 0% | +$0 | 0.71 | |
Stoke Therapeutics, Inc. STOK | $1.96M | 0.28 | 145,000 | New | +$1.96M | 0.46 | |
Arcus Biosciences, Inc. RCUS | $4.37M | 0.26 | 231,717 | -0.43% | -$18,880.00 | 1.02 | |
ARS Pharmaceuticals, Inc. SPRY | $2.44M | 0.25 | 239,194 | -23.13% | -$735,584.60 | 0.57 | |
Galapagos NV GLPG | $4.19M | 0.2 | 130,175 | 0% | +$0 | 0.97 | |
Keros Therapeutics, Inc. KROS | $4.49M | 0.19 | 67,754 | -8.88% | -$437,383.42 | 1.04 | |
Viking Therapeutics, Inc. VKTX | $15.92M | 0.18 | 194,117 | -21.8% | -$4.44M | 3.7 | |
Blueprint Medicines Corporation BPMC | $10.13M | 0.17 | 106,763 | -3.7% | -$388,925.99 | 2.35 | |
Ascendis Pharma A/S ASND | $13.98M | 0.16 | 92,472 | -25.11% | -$4.69M | 3.25 | |
Immatics N.V. IMTX | $1.52M | 0.14 | 145,000 | +38.09% | +$420,400.00 | 0.35 | |
Biohaven Pharmaceutical Holding Company Ltd. BHVN | $6.49M | 0.13 | 118,730 | -29.65% | -$2.74M | 1.51 | |
PROCEPT BioRobotics Corporation PRCT | $2.72M | 0.11 | 54,995 | -13.12% | -$410,433.11 | 0.63 | |
Neurocrine Biosciences, Inc. NBIX | $9.88M | 0.07 | 71,615 | -1.38% | -$137,920.00 | 2.3 | |
Insulet Corporation PODD | $2.73M | 0.02 | 15,900 | New | +$2.73M | 0.63 | |
DexCom, Inc. DXCM | $9.09M | 0.02 | 65,552 | -2.96% | -$277,399.99 | 2.11 | |
BioNTech SE BNTX | $1.57M | 0.01 | 17,000 | New | +$1.57M | 0.37 | |
BrainsWay Ltd. BWAY | $1.57M | <0.01 | 297,655 | -3.51% | -$57,216.64 | 0.37 | |
iShares Biotechnology ETF IBB | $14.07M | <0.01 | 102,500 | 0% | +$0 | 3.27 | |
SPDR S&P Biotech ETF XBI | $40.92M | <0.01 | 431,215 | -10.91% | -$5.01M | 9.51 |